Dergiler / Türk Patoloji Dergisi / 2017 / Cilt: 33 - Sayı: 2

What does the Data of 354,725 Patients from Turkey Tell Us About Cervical Smear Epithelial Cell Abnormalities? - The Epithelial Cell Abnormality Rate is Increasing - Quality Control Studies and Corrective Activity are Musts

Sayfa
134–143
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A cervical cytology subspecialist in every center can be utopic but a dedicated pathologist in the center is certainly needed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: There is no other screening program close to the success rate of PAP test.
📊
Temel Bulgular & Veri:The study was conducted with Turkish gynaecopathology working group and 38 centers (totally 45 hospitals) agreed to contribute from 24 different cities.
💡
Sonuç & Katkı:A cervical cytology subspecialist in every center can be utopic but a dedicated pathologist in the center is certainly needed.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: There is no other screening program close to the success rate of PAP test. Cervical cytology constitutes a large workload so that quality control in cervical cytology is important for the quality assurance of pathology laboratories. Material and Method: In this study, we collected the cervical cytology results from all over Turkey and discussed the parameters influencing the quality of the PAP test. The study was conducted with Turkish gynaecopathology working group and 38 centers (totally 45 hospitals) agreed to contribute from 24 different cities. The study was designed to cover the cervical cytology results during 2013. The results were evaluated from the data based on an online questionnaire.Results: The total number of epithelial Cell Abnormality was 18,020 and the global epithelial Cell Abnormality rate was 5.08% in the total 354,725 smears and ranging between 0.3% to 16.64% among centers. The Atypical squamous cells /squamous intraepithelial lesion ratios changed within the range of 0.21-13.94 with an average of 2.61. When the centers were asked whether they performed quality assurance studies, only 14 out of 28 centers, which shared the information, had such a control study and some quality parameters were better in these centers.Conclusion: There is an increase in the global epithelial Cell Abnormality rate and there are great differences among centers. Quality control studies including the Atypical squamous cells/squamous intraepithelial lesion ratio are important. Corrective and preventive action according to quality control parameters is a must. A cervical cytology subspecialist in every center can be utopic but a dedicated pathologist in the center is certainly needed.

🔖

Bu Makaleye Atıf Yap

ÇAKIR, A., ERDOĞAN, K. E., USUBÜTÜN, A., ERDOĞAN, G., ÇOBANOĞLU, B., ALTINAY, S., ARICI, S., ASTARCI, M., AKBULUT, M., DEMİR, H., BOLAT, F. A., EREN, F., ASLAN, F., DOĞAN, H. T., EKEN, K. G., ERHAN, S. Ş., TÜRKMEN, İ. Ç., AYDIN, Ö., Ab, A. (2022). What does the Data of 354,725 Patients from Turkey Tell Us About Cervical Smear Epithelial Cell Abnormalities? - The Epithelial Cell Abnormality Rate is Increasing - Quality Control Studies and Corrective Activity are Musts. Türk Patoloji Dergisi, Cilt: 33 - Sayı: 2, 134–143. https://ajindex.com/articles/640513

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. GLOBOCAN 2012, Available at: http://globocan.iarc.fr/Pages/ fact_sheets_cancer.aspx 2. Türkiye kanser istatistikleri, 2012, Available at: http://kanser.gov. tr/Dosya/2015haberler1/ANA_rapor_2012v02.pdf 3. Türkmen IÇ, Başsüllü N, Korkmaz P, Günenç B, Baykal CM, Güdücü N, Işçı H, Dünder I, Doğusoy GB. Patients with epithelial cell abnormality in PAP smears: Correlation of results with follow-up smears and cervical biopsies. Turk Patoloji Derg. 2013
  2. Kaygusuz EI, Cetiner H, Sahin D. LSIL/ASC-H (LSIL-H) in cervicovaginal smear: Histopathological outcomes and clinical significance. Turk Patoloji Derg 2011
  3. Mehmetoglu HC, Sadikoglu G, Ozcakir A, Bilgel N: Pap smear screening in the primary health care setting: A study from Turkey. N Am J Med Sci 2010
  4. Abali R, Bacanakgıl BH, Celik S, Aras O, Koca P, Boran B, Dursun N. Histopathological correlation of squamous cell abnormalities detected on cervical cytology. Turk Patoloji Derg. 2011
  5. Boztosun A, Mutlu AM, Ozer H, Aker H, Yanık A: Servikovajinal smearde epitelyal hucre anomalisi saptanan hastaların kolposkopik biyopsi sonuclarının degerlendirilmesi. Turk Jinekolojik Onkoloji Dergisi 2012, 1:13-19. 8. Atilgan R, Celik A, Boztosun A, Ilter E, Yalta T, Ozercan R: Evaluation of cervical cytological abnormalities in Turkish population. Indian J Pathol Microbiol 2012, 55:52-55. 9. Kır G, Karateke A, Aker F: ASCUS, LSIL ve HSIL tanılarının sitohistolojik korelasyonu, Bethesda 2001 ASCUS alt gruplarının irdelenmesi. Turk Patoloji Derg 2003, 19:14-16. 10. Coskun A, Kostu B, Kıran G, Arıkan DC, Analan A: Pap Smear screening results in Kahramanmaras. Gynecol Obstet Reprod Med 2008,14:182-185. 11. Ersoz S, Reis A, Baki N: Trabzon ilinde Servikal Tarama Programı. Turk Jinekolojik Onkoloji Dergisi 2010, 7:35-39. 12. Isaoglu U, Yilmaz M, Delibas IB, Bilici AE, Kabalar ME. Evaluation of 37,438 consecutive cervical smear results in the Turkish population. Arch Med Sci. 2015 Apr 25
  6. 11(2):402-5. 13. Nayir T, Okyay RA, Nazlican E, Yesilyurt H, Akbaba M, Ilhan B, Kemik A. Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey. Asian Pac J Cancer Prev. 2015
  7. 16(16):6909-12. 14. Turkish Cervical Cancer And Cervical Cytology Research Group: Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009, 106:206-209. 15. Tworek J, Nayar R, Savaloja L, Tabbara S, Thomas N, Winkler B, Howell LP. General quality practices in gynecologi